Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors
Apply
HM16390 & Pembrolizumab
Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step